NeoPharm
092730.KQ
13.45 USD
-0.27
-1.97%
n
Overview
Last close
13.45 usd
Market cap
107.47M usd
52 week high
14.24 usd
52 week low
7.28 usd
Target price
25.86 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1.2062
Price/Book Value
1.6432
Enterprise Value
122.09M usd
EV/Revenue
1.3735
EV/EBITDA
5.0872
Key financials
Revenue TTM
62.34M usd
Gross Profit TTM
44.81M usd
EBITDA TTM
16.66M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
145.50M usd
Net debt
N/A usd
About
NeoPharm CO., LTD. manufactures and sells skin care products in South Korea. The company offers Atopalm, a non-steroid product for sensitive and dry skin; skin dermo-cosmetic products under the Real Barrier brand; products for sensitive, dry, oily, or trouble-prone skin under the ZEROID brand; body moisturizers under the Derma-B brand; and sport care products for athletes under the MISSION ATHELETCARE brand. NeoPharm CO., LTD. was founded in 2000 and is headquartered in Daejeon, South Korea.
- Symbol092730.KQ
- ExchangeKQ
- IsinKR7092730001
- CountrySouth Korea
- SectorConsumer Non-Cyclicals
- IndustryPersonal & Household Products & Services
- CEOByeong-Deog Park
- HeadquarterDaejeon
- Web sitehttps://www.neopharm.co.kr
